Scientists have created a “mini-brain” model, the size of a grain of rice, from human stem cells that can mimic multiple sclerosis (MS)-related damage and repair, offering a new avenue for testing drugs that restore the myelin sheath surrounding nerve fibers. The 3D spheroid model contains human nerve cells…
Discussion
Quantum Biopharma is collaborating with Thermo Fisher Scientific to prepare a Phase 2 clinical trial of Lucid-MS, an experimental oral therapy designed to slow myelin loss, in people with progressive forms of multiple sclerosis (MS). Under the agreement, Thermo Fisher’s PPD clinical research business will support…
Discussion
There’s something about the first signs of cooler weather that makes me pause and feel alive again. The days are getting shorter, the mornings feel a little different, and the air finally has a hint of crispness. After months of central Texas heat, it’s comforting to know that cooler weather…
Discussion
A brief, personalized neuropsychological rehabilitation program may help people with multiple sclerosis (MS) manage cognitive difficulties, according to a feasibility study. Participants reported improvements in their ability to use cognitive strategies, plan daily activities, and cope with fatigue. The study (ISRCTN11203922)Â showed that the program, called Neuropsychological Evaluation and…
Discussion
Higher levels of physical activity may be associated with a lower likelihood of developing multiple sclerosis (MS), mainly among people with low sun exposure, a Swedish study suggests. The study assessed leisure-time physical activity and sun exposure. In the overall population, no clear overall association was found between physical…
Get regular updates to your inbox.
